查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1727993

美國醫藥低溫運輸包裝市場規模、佔有率、趨勢分析報告：按包裝類型、基材、溫度要求、產品、組件、應用、細分預測，2025-2030 年

U.S. Pharmaceutical Cold Chain Packaging Market Size, Share & Trends Analysis Report By Packaging Format, By Substrate, By Temperature Requirement, By Product, By Component, By Application, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國醫藥低溫運輸包裝市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，美國醫藥低溫運輸包裝市場規模預計到2030年將達到27.8億美元，2025年至2030年期間的複合年成長率為14.6%。

這是由於溫度敏感藥物、疫苗和生技藥品的生產和分銷增加所致。生物製藥、個人化醫療以及細胞和基因療法的進步推動了對能夠在儲存和運輸過程中保持精確溫度條件的專用低溫運輸解決方案的需求。此外，電子商務藥品分銷的不斷成長、嚴格的監管要求以及對永續性的日益關注進一步推動了醫藥低溫運輸包裝和物流市場的成長。

製藥業正在向生物製藥轉變，包括單株抗體、重組蛋白和mRNA疫苗。這些生技藥品需要嚴格的溫度控制來維持效力和效果。大多數生技藥品在運送過程中需要冷藏（2°C 至 8°C）、冷凍（-20°C）或超冷藏（-80°C 或更低）。此類高價值醫藥產品的日益普及導致對低溫運輸基礎設施的投資增加，包括隔熱包裝、即時監控系統和溫控儲存設施。

例如，基於mRNA的新冠疫苗的成功凸顯了超低溫低溫運輸物流的需求，促使企業擴大冷藏能力並投資於創新包裝解決方案。生技藥品在癌症、自體免疫疾病和罕見疾病治療中的持續成長預計將使對先進醫藥低溫運輸解決方案的需求保持在高位。

此外，細胞和基因治療市場正在迅速擴張，美國在臨床試驗和商業發布方面處於領先地位。這些創新治療方法包含活細胞和遺傳物質，需要低溫儲存（低於-150°C）才能保持活力。 CAR-T細胞療法、幹細胞療法和基因編輯技術需要專門的低溫運輸物流來確保從製造到患者管理的產品完整性。

隨著FDA核准的個人化治療數量不斷增加，迫切需要基於液態氮的低溫儲存解決方案、有效的絕緣包裝和準確的追蹤系統。低溫運輸物流供應商正在投資專用冷凍庫、低溫運輸機和智慧追蹤解決方案，以滿足對這些高度敏感的治療劑日益成長的需求。

許多患者，尤其是患有慢性疾病的患者，現在透過郵購藥局或訂閱式藥物配送服務來獲得藥物。這種轉變推動了對緊湊、經濟高效的絕緣包裝解決方案的需求，這些解決方案可以在最後一英里的運送過程中保持溫度穩定。

領先的製藥公司和物流供應商正在擴大其低溫運輸配送網路，以確保及時、溫控配送。隔熱郵件、冷藏運輸卡車和支援物聯網的追蹤設備正在被廣泛採用，以滿足對溫度敏感的藥品運輸日益成長的需求。

美國醫藥低溫運輸包裝市場報告重點

  • 預計到 2024 年，發泡聚苯乙烯 (EPS) 基材部分將佔據最大的市場收益佔有率，超過 15.2%。發泡聚苯乙烯 (EPS) 基材因其出色的絕緣性能、輕質結構、成本效益和易於定製而佔據市場主導地位。
  • 盒裝產品領域在 2024 年佔據了最大的市場收益佔有率，超過 51.6%，這得益於其提供可靠絕緣、易於操作、成本效益高以及在整個醫藥供應鏈中廣泛使用等卓越能力。
  • 絕緣組件部門在 2024 年佔據最大的市場收益佔有率，超過 73.9%。在疫苗、生技藥品、胰島素和特殊藥物等對溫度敏感的藥品的運輸和儲存過程中，隔熱材料對於維持所需的溫度範圍起著關鍵作用。
  • 美國醫藥低溫運輸包裝產業競爭激烈，主要企業不斷創新，以滿足對溫度敏感的醫藥產品運輸日益成長的需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國醫藥低溫運輸包裝市場變數、趨勢與範圍

  • 市場展望
  • 滲透和成長前景圖
  • 產業價值鏈分析
  • 科技趨勢
  • 法律規範
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 商業環境分析
    • 波特五力分析
    • PESTEL分析

第4章：美國醫藥低溫運輸包裝市場：依包裝類型估價與趨勢分析

  • 關鍵要點
  • 2024年及2030年包裝形式趨勢分析及市場佔有率
    • 積極的
    • 被動的

第5章美國醫藥低溫運輸包裝市場：按溫度要求的估計和趨勢分析

  • 關鍵要點
  • 2024年及2030年包裝形式趨勢分析及市場佔有率
    • 室溫控制（15度C~25度C）
    • 冷藏（2度C至8度C）
    • 冷凍（0度C以下）
    • 冷凍（-20度C至-40度C）
    • 極低溫（-150度C以下）

第6章美國醫藥低溫運輸包裝市場：依基材的估計與趨勢分析

  • 關鍵要點
  • 2024年及2030年基材趨勢分析及市場佔有率
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚對苯二甲酸乙二醇酯（PET）
    • 發泡聚苯乙烯（EPS）
    • 聚氨酯（PU）
    • 真空絕熱板（VIP）
    • 隔熱包裝（TIP）
    • 金屬
    • 其他

第7章美國醫藥低溫運輸包裝市場：按產品分類的估計和趨勢分析

  • 關鍵要點
  • 2024 年及 2030 年產品趨勢分析及市場佔有率
    • 盒子
    • 梅勒
    • 調色盤
    • 其他

第8章美國醫藥低溫運輸包裝市場：按組成部分的估計和趨勢分析

  • 關鍵要點
  • 2024 年和 2030 年各組件的市場佔有率
    • 冷卻液
    • 絕緣

第9章：美國醫藥低溫運輸包裝市場：按應用的估計和趨勢分析

  • 關鍵要點
  • 2024 年及 2030 年各應用領域的趨勢分析及市場佔有率
    • 生物製藥公司
    • 臨床研究所
    • 醫院
    • 研究機構
    • 物流配送公司
    • 其他

第10章 競爭格局

  • 全球主要參與者和最新趨勢及其對該行業的影響
  • 公司/競爭對手分類
  • 供應商格局
    • 原物料供應商名單
  • 企業市場分析
  • 公司熱圖分析
  • Company Dashboard Analysis
  • 戰略地圖
    • 擴張
    • 合併與收購
    • 合作/夥伴關係/協議
    • 新產品發布
    • 其他

第11章 公司列表（概述、財務表現、產品概述）

  • Insulated Products Corporation
    • 公司簡介
    • 財務表現
    • 產品基準
  • Sealed Air
  • Peli BioThermal Limited
  • CSafe
  • Intelsius
  • Sonoco ThermoSafe
  • Cryoport Systems, LLC
  • SkyCell AG
  • Inmark Global Holdings, LLC
  • Smurfit Kappa
Product Code: GVR-4-68040-548-3

U.S. Pharmaceutical Cold Chain Packaging Market Growth & Trends:

The U.S. pharmaceutical cold chain packaging market size is anticipated to reach USD 2.78 billion by 2030 and is projected to grow at a CAGR of 14.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is due to the increasing production and distribution of temperature-sensitive drugs, vaccines, and biologics. With advancements in biopharmaceuticals, personalized medicine, and cell & gene therapies, there is a rising need for specialized cold chain solutions that can maintain precise temperature conditions throughout storage and transportation. In addition, the expansion of e-commerce-based drug distribution, stringent regulatory requirements, and a growing focus on sustainability are further driving the market growth for pharmaceutical cold chain packaging and logistics.

The pharmaceutical industry is shifting toward biopharmaceuticals, which include monoclonal antibodies, recombinant proteins, and mRNA vaccines. These biologics require strict temperature control to maintain their potency and efficacy. Most biologics need cold storage (2°C to 8°C), frozen storage (-20°C), or ultra-cold storage (-80°C or lower) during transportation. The rising adoption of these high-value drugs has led to increased investment in cold chain infrastructure, including insulated packaging, real-time monitoring systems, and temperature-controlled storage facilities.

For instance, the success of mRNA-based COVID-19 vaccines highlighted the necessity for ultra-cold chain logistics, prompting companies to expand their cold storage capabilities and invest in innovative packaging solutions. With the continued growth of biologics in treating cancer, autoimmune diseases, and rare disorders, the demand for advanced pharmaceutical cold chain solutions is expected to remain high.

Moreover, the cell & gene therapy market is rapidly expanding, with the U.S. leading in clinical trials and commercial launches. These innovative therapies involve living cells and genetic material, requiring cryogenic storage (-150°C or lower) to preserve viability. CAR-T cell therapies, stem cell treatments, and gene-editing technologies demand specialized cold chain logistics to ensure product integrity from the point of manufacturing to patient administration.

With the rising number of FDA approvals for personalized therapies, there is an urgent need for liquid nitrogen-based cryogenic storage solutions, validated insulated packaging, and precise tracking systems. Cold chain logistics providers are investing in specialized freezers, cryogenic shippers, and smart tracking solutions to support the growing demand for these highly sensitive treatments.

The rise of online pharmacies and direct-to-patient drug delivery is another key factor fueling the demand for pharmaceutical cold chain logistics in the U.S. Many patients, especially those with chronic conditions, now receive medications via mail-order pharmacies and subscription-based drug delivery services. This shift has increased the need for compact, cost-efficient, and insulated packaging solutions that can maintain temperature stability during last-mile distribution.

Leading pharmaceutical companies and logistics providers are expanding cold chain distribution networks to ensure timely and temperature-controlled deliveries. Insulated mailers, refrigerated delivery trucks, and IoT-enabled tracking devices are being widely adopted to support the growing demand for temperature-sensitive drug distribution.

U.S. Pharmaceutical Cold Chain Packaging Market Report Highlights:

  • The Expanded Polystyrene (EPS) substrate segment recorded the largest market revenue share of over 15.2% in 2024. Expanded Polystyrene (EPS) substrate is dominating the market due to its superior insulating properties, lightweight structure, cost-effectiveness, and ease of customization.
  • The boxes product segment recorded the largest market revenue share of over 51.6% in 2024 due to its superior ability to provide reliable thermal insulation, ease of handling, cost-effectiveness, and widespread use across the pharmaceutical supply chain.
  • The insulation component segment recorded the largest market revenue share of over 73.9% in 2024. Insulation materials play a critical role in maintaining the required temperature range for temperature-sensitive pharmaceuticals such as vaccines, biologics, insulin, and specialty drugs during transportation and storage.
  • The U.S. pharmaceutical cold chain packaging industry is highly competitive, with key players continuously innovating to meet the growing demand for temperature-sensitive drug transportation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
    • 1.1.1. Market Segmentation
    • 1.1.2. Market Definition
  • 1.2. Research Scope & Assumptions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot, 2024 (USD Million)
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Pharmaceutical Cold Chain Packaging Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
  • 3.4. Technology Trends
  • 3.5. Regulatory Framework
  • 3.6. Market Dynamics
    • 3.6.1. Market Driver Analysis
    • 3.6.2. Market Restraint Analysis
    • 3.6.3. Market Opportunity Analysis
    • 3.6.4. Market Challenge Analysis
  • 3.7. Business Environment Analysis
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. U.S. Pharmaceutical Cold Chain Packaging Market: Packaging Format Estimates & Trend Analysis

  • 4.1. Key Takeaways
  • 4.2. Packaging Format Movement Analysis & Market Share, 2024 & 2030
    • 4.2.1. Active
      • 4.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Passive
      • 4.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Pharmaceutical Cold Chain Packaging Market: Temperature Requirement Estimates & Trend Analysis

  • 5.1. Key Takeaways
  • 5.2. Packaging Format Movement Analysis & Market Share, 2024 & 2030
    • 5.2.1. Controlled Room Temperature (15°C - 25°C)
      • 5.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Refrigerated (2°C - 8°C)
      • 5.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Frozen (0°C and below)
      • 5.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Deep-Frozen (-20°C to -40°C)
      • 5.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.5. Cryogenic (-150°C and below)
      • 5.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Pharmaceutical Cold Chain Packaging Market: Substrate Estimates & Trend Analysis

  • 6.1. Key Takeaways
  • 6.2. Substrate Movement Analysis & Market Share, 2024 & 2030
    • 6.2.1. Polyethylene (PE)
      • 6.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Polypropylene (PP)
      • 6.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Polyethylene Terephthalate (PET)
      • 6.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Expanded Polystyrene (EPS)
      • 6.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.5. Polyurethane (PU)
      • 6.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.6. Vacuum Insulated Panel (VIP)
      • 6.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.7. Temperature Insulated Packaging (TIP)
      • 6.2.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.8. Metal
      • 6.2.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.9. Others
      • 6.2.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Pharmaceutical Cold Chain Packaging Market: Product Estimates & Trend Analysis

  • 7.1. Key Takeaways
  • 7.2. Product Movement Analysis & Market Share, 2024 & 2030
    • 7.2.1. Boxes
      • 7.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. Mailers
      • 7.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Pallets
      • 7.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Others
      • 7.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Pharmaceutical Cold Chain Packaging Market: Component Estimates & Trend Analysis

  • 8.1. Key Takeaways
  • 8.2. Component Movement Analysis & Market Share, 2024 & 2030
    • 8.2.1. Coolant
      • 8.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. Insulation
      • 8.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Pharmaceutical Cold Chain Packaging Market: Application Estimates & Trend Analysis

  • 9.1. Key Takeaways
  • 9.2. Application Movement Analysis & Market Share, 2024 & 2030
    • 9.2.1. Biopharmaceutical Companies
      • 9.2.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. Clinical Research Organizations
      • 9.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Hospitals
      • 9.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Research Institutes
      • 9.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.5. Logistics and Distribution Companies
      • 9.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.6. Others
      • 9.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Key Global Players & Recent Developments & Their Impact on the Industry
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of Raw Material Suppliers
  • 10.4. Company Market Position Analysis
  • 10.5. Company Heat Map Analysis
  • 10.6. Company Dashboard Analysis
  • 10.7. Strategy Mapping
    • 10.7.1. Expansions
    • 10.7.2. Mergers & Acquisitions
    • 10.7.3. Collaborations/Partnerships/Agreements
    • 10.7.4. New Product Launches
    • 10.7.5. Others

Chapter 11. Company Listing (Overview, Financial Performance, Products Overview)

  • 11.1. Insulated Products Corporation
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
  • 11.2. Sealed Air
  • 11.3. Peli BioThermal Limited
  • 11.4. CSafe
  • 11.5. Intelsius
  • 11.6. Sonoco ThermoSafe
  • 11.7. Cryoport Systems, LLC
  • 11.8. SkyCell AG
  • 11.9. Inmark Global Holdings, LLC
  • 11.10. Smurfit Kappa

List of Tables

  • Table 1. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Packaging Format, 2018 - 2030 (USD Million)
  • Table 2. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Temperature Requirement, 2018 - 2030 (USD Million)
  • Table 3. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Substrate, 2018 - 2030 (USD Million)
  • Table 4. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
  • Table 5. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Component, 2018 - 2030 (USD Million)
  • Table 6. U.S. Pharmaceutical Cold Chain Packaging market estimates and forecasts, by Application, 2018 - 2030 (USD Million)

List of Figures

  • 1. Information Procurement
  • 2. Primary Research Pattern
  • 3. Primary Research Process
  • 4. Market Research Approaches - Bottom-Up Approach
  • 5. Market Research Approaches - Top-Down Approach
  • 6. Market Research Approaches - Combined Approach
  • 7. Market Snapshot
  • 8. Segment Snapshot (1/2)
  • 9. U.S. Pharmaceutical Cold Chain Packaging Market - Segment Snapshot (2/2)
  • 10. U.S. Pharmaceutical Cold Chain Packaging Market - Competitive Landscape Snapshot
  • 11. U.S. Pharmaceutical Cold Chain Packaging Market: Penetration & Growth Prospect Mapping
  • 12. U.S. Pharmaceutical Cold Chain Packaging Market: Value Chain Analysis
  • 13. U.S. Pharmaceutical Cold Chain Packaging Market: Porter's Five Force Analysis
  • 14. U.S. Pharmaceutical Cold Chain Packaging Market: PESTEL Analysis
  • 15. U.S. Pharmaceutical Cold Chain Packaging Market: Packaging Format Movement Analysis, 2024 & 2030
  • 16. U.S. Pharmaceutical Cold Chain Packaging Market: Temperature Requirement Movement Analysis, 2024 & 2030
  • 17. U.S. Pharmaceutical Cold Chain Packaging Market: Substrate Movement Analysis, 2024 & 2030
  • 18. U.S. Pharmaceutical Cold Chain Packaging Market: Component Movement Analysis, 2024 & 2030
  • 19. U.S. Pharmaceutical Cold Chain Packaging Market: Product Movement Analysis, 2024 & 2030
  • 20. U.S. Pharmaceutical Cold Chain Packaging Market: Application Movement Analysis, 2024 & 2030
  • 21. U.S. Pharmaceutical Cold Chain Packaging Market: Company Positioning Analysis
  • 22. U.S. Pharmaceutical Cold Chain Packaging Market: Market Dashboard Analysis
  • 23. U.S. Pharmaceutical Cold Chain Packaging Market: Strategy Mapping